KCNK9 anticorps (AA 265-374)
Aperçu rapide pour KCNK9 anticorps (AA 265-374) (ABIN6142756)
Antigène
Voir toutes KCNK9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 265-374
-
Séquence
- AGNRNSMVIH IPEEPRPSRP RYKADVPDLQ SVCSCTCYRS QDYGGRSVAP QNSFSAKLAP HYFHSISYKI EEISPSTLKN SLFPSPISSI SPGLHSFTDH QRLMKRRKSV
-
Réactivité croisée
- Humain, Souris
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 265-374 of human KCNK9 (NP_001269463.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Commentaires
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KCNK9 (Potassium Channel, Subfamily K, Member 9 (KCNK9))
-
Autre désignation
- KCNK9
-
Sujet
- This gene encodes a protein that contains multiple transmembrane regions and two pore-forming P domains and functions as a pH -dependent potassium channel. Amplification and overexpression of this gene have been observed in several types of human carcinomas. This gene is imprinted in the brain, with preferential expression from the maternal allele. A mutation in this gene was associated with Birk-Barel mental retardation dysmorphism syndrome. Alternative splicing results in multiple transcript variants.,KCNK9,K2p9.1,KT3.2,TASK-3,TASK3,Cancer,Neuroscience,KCNK9
-
Poids moléculaire
- 42 kDa
-
ID gène
- 51305
-
UniProt
- Q9NPC2
Antigène
-